Complete Genomics is an established technology leader in technology for whole human genome sequencing based in San Jose, California. Using its proprietary sequencing instruments, chemistry, and software, the company has sequenced more than 20,000 whole human genomes. Our company’s mission from inception has been to help improve human health by providing researchers and clinicians with the core technologies to understand, prevent, diagnose, and treat diseases and conditions using genomic information.
Complete Genomics was founded in 2006 and in March 2013 was acquired by BGI-Shenzhen, the world’s largest genomics services company. BGI is headquartered in Shenzhen, China and provides sequencing and bioinformatics services and systems for research, medical, agricultural, and environmental applications.
In June 2018, Complete Genomics became part of MGI, which is the instruments manufacturing business of BGI. As part of MGI, Complete Genomics now serves as a research and development center of excellence. Complete Genomics continues to focus on improving its technology and helping MGI to build next-generation sequencing systems and applications for the research, clinical, and consumer markets.
The team at Complete Genomics also functions in close coordination with other BGI sister companies in North America. MGI Americas is the commercial arm of MGI in the Americas Region focused on instruments. BGI Americas provides genomics sequencing services in the Americas Region.
For more information on the global MGI business, please visit https://en.mgi-tech.com. For more information on MGI Americas, please visit https://mgiamericas.com/. For information on BGI Americas, please visit https://www.bgi.com/us/. For more information on BGI, please visit https://www.bgi.com/global/.